| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1373437 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
Previously N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin 1 has been shown to display properties associated with inhibition of angiogenesis. Here we examined the anti-tumourigenic role of 1 in a lung cancer cell line. This agent altered cell surface oligosaccharide expression and inhibited the growth of A549 cells by inducing G1 phase cell cycle arrest and apoptosis. Furthermore, stress fibre assembly and cell migration in A549 cells was markedly suppressed by 1.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yunxue Zhao, Wenjia Liu, Ying Zhou, Xiumei Zhang, Paul V. Murphy,